Canadian Gastric Cancer Association

Multivisceral Resection

What types of surgery are available to someone with gastric cancer?

Most patients who are diagnosed with resectable gastric cancer will have a gastrectomy. In short, this surgery cuts out part of (or the whole) stomach. Gastrectomy is usually accompanied by a lymphadenectomy, where some of the lymph nodes near the stomach are taken out too. This helps prevent the spread of disease.

But, in some cases it can be helpful to remove other organs in the abdomen as well. This might be necessary for two main reasons: firstly, if the cancer has directly spread to this area. Or, the doctor might think it is very likely that the cancer could spread to these organs and would remove them to avoid this.


Which other organs might be taken out in a surgery for stomach cancer? Why?

These structures are particularly important to consider in gastric cancer because they are located near the stomach. This means that the cancer is more likely to spread to these locations than other places in the body which are further away.  Removing multiple organs is called a multivisceral resection; “multivisceral” literally means “more than one organ”.


How can a doctor tell if they got all the cancer out?

It is usually difficult to answer this question for sure, especially because cancer can recur if even one diseased cell is left in the body. But, a good way to assess if most of the tumor is removed is by looking at the margins (borders), using the R classification system. After a surgeon removes a tumor, the cut-out sample is sent to the lab. Here, a pathologist looks at the sample under a microscope and identifies what “margins” the surgery was able to achieve:


These papers by Dr. Coburn and her research team try to address some major questions about when it is appropriate to remove multiple organs, which organs should be taken out, and what the consequences are.

Brar, Savtaj S., et al. Gastric Cancer 15.1 (2012): 89–99. https://www.ncbi.nlm.nih.gov/pubmed/21915699

What question are they asking?

  1. The pros and cons of removing the spleen and pancreas even if they do not show signs of cancer.
  2. Whether removal is useful if doctors believe cancer could spread there.
  3. Whether removal helps access nearby lymph nodes.

How did they address their question?

  • They reviewed 40 articles involving 6,354 patients worldwide.

What did they find?

  1. Removing the spleen and pancreas seems to decrease short-term complications after surgery.
  2. Removing them did not significantly change overall survival.
  3. They concluded it is not unsafe to remove the spleen and lymph nodes, but long-term benefits are still unclear.

Brar, Savtaj S., et al. Gastric Cancer 15.1 (2012): 100–107.

https://www.ncbi.nlm.nih.gov/pubmed/21785926

What question are they asking?

  1. Does multivisceral resection help remove more cancer without harming the patient?
  2. They focused on patients with advanced gastric cancer (T4 tumors).

How did they address their question?

  • They summarized 17 articles from around the world.
  • Organs most commonly removed: spleen, pancreas, liver, transverse colon.

What did they find?

  1. If R0 margins were not achieved, survival was worse.
  2. Patients lost major organs but still had cancer, leading to worse outcomes.
  3. This surgery should only be used when cancer has clearly spread to these organs.
  4. It is helpful only when it can achieve R0 margins in late-stage cancer.

Roberts, Patrick, et al. Gastric Cancer 15.1 (2012): 108–115.

What question are they asking?

  1. When the pancreas is invaded, one option is gastrectomy with pancreaticoduodenectomy (PD), where diseased parts of the pancreas and duodenum are removed.
  2. They studied the risks and benefits of PD for gastric cancer.

How did they address their question?

  • This study reviewed 8 articles from around the world

What did they find?

  1. PD can cause a complication called pancreatic leak, where pancreatic fluid escapes and damages nearby organs.
  2. Despite this, PD can improve survival if it helps achieve R0 margins in patients whose cancer has spread to the pancreas.
  3. PD should not be used unless the cancer has directly invaded the pancreas.
  4. Chemotherapy and/or radiation therapy can also help in advanced gastric cancer.